Low plasma vitamin B12 is associated with lower BMD:: The Framingham Osteoporosis Study

被引:69
|
作者
Tucker, KL
Hannan, MT
Qiao, N
Jacques, PF
Selhub, J
Cupples, LA
Kiel, DP
机构
[1] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[2] Harvard Univ, Sch Med, Hebrew Rehabil Ctr Aged Res & Training INst, Boston, MA 02115 USA
[3] Boston Univ, Sch Publ Hlth, Boston, MA USA
关键词
vitamin B-12; cyanocobalamin; BMD; epidemiology;
D O I
10.1359/JBMR.041018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin B-12 is important to DNA synthesis and may affect bone formation. We examined the association between this vitamin and BMD in 2576 adults. Men with plasma B-12 < 148 pM had significantly lower BMD at the hip, and women at the spine, relative to those with higher B-12, and trends were similar for both at all sites. Low vitamin B-12 may be a risk factor for low BMD. Introduction: Vitamin B-12 is important to DNA synthesis and may affect bone formation. It has been linked to osteoblastic activity in clinical studies and cell culture. Materials and Methods: We examined the relationship between plasma vitamin B-12 status and BMD in 2576 adult participants in the Framingham Offspring Osteoporosis Study (1996-2001). BMD was measured by DXA at the hip and spine. Plasma vitamin B-12 was measured by radioassay. Mean BMD measures were estimated for four categories of vitamin B-12 concentration, based on commonly used cut-offs, using analysis of covariance, adjusted for age, BMI, physical activity score for the elderly (PASE), alcohol use, smoking status, total calcium and vitamin D intake, season of bone measurement, and for women, menopause status and current estrogen use. Further adjustment for protein intake and total homocysteine concentration was also performed. Results: Both men and women with vitamin B-12 concentrations <148 pM had lower average BMD than those with vitamin B 12 above this cut-off. These differences were significant (p < 0.05) for men at most hip sites and for women at the spine. Significance remained after further adjustment for protein intake and plasma homocysteine.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [41] Homocysteine, folate and vitamin B12 in seminal plasma
    Crha, I.
    Kubesova, J.
    Kralikova, M.
    Tallova, J.
    Jarkovsky, J.
    Zakova, J.
    Ventruba, P.
    [J]. HUMAN REPRODUCTION, 2007, 22 : I218 - I218
  • [42] PLASMA THIOCYANATE AND VITAMIN B12 IN NEUROLOGICAL DISEASE
    MATTHEWS, DM
    WILSON, J
    [J]. LANCET, 1966, 2 (7468): : 861 - &
  • [43] PLASMA THIOCYANATE AND VITAMIN B12 IN NEUROLOGICAL DISEASE
    MOORE, DF
    [J]. LANCET, 1966, 1 (7451): : 1377 - &
  • [44] PLASMA THIOCYANATE AND VITAMIN B12 IN NEUROLOGICAL DISEASE
    SMITH, ADM
    [J]. LANCET, 1966, 1 (7448): : 1207 - &
  • [45] VITAMIN B12
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1968, 4 (5624): : 167 - +
  • [46] VITAMIN B12
    DERSE, PH
    [J]. JOURNAL OF THE ASSOCIATION OF OFFICIAL AGRICULTURAL CHEMISTS, 1965, 48 (06): : 1269 - +
  • [47] VITAMIN B12
    HEINRICH, HC
    [J]. SCIENCE, 1966, 152 (3722) : 633 - &
  • [48] VITAMIN B12
    KISLIUK, RL
    [J]. QUARTERLY REVIEW OF BIOLOGY, 1966, 41 (01): : 84 - &
  • [49] VITAMIN B12
    不详
    [J]. LANCET, 1965, 1 (7400): : 1372 - &
  • [50] VITAMIN B12
    PETROW, V
    [J]. CHEMISTRY & INDUSTRY, 1965, (37) : 1588 - &